Brève : La FDA autorise un test BioMérieux coronavirus sur échantillons groupés.

Manus JM

DOI: 10.1016/s1773-035x(21)00045-9
Published: 2021 Mar
Container: Revue francophone des laboratoires : RFL
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1773-035x-21-00045-9,
  title = {Brève : La FDA autorise un test BioMérieux coronavirus sur échantillons groupés.},
  author = {Manus JM},
  year = {2021},
  journal = {Revue francophone des laboratoires : RFL},
  doi = {10.1016/s1773-035x(21)00045-9},
  url = {https://doi.org/10.1016/s1773-035x(21)00045-9}
}

RIS

TY  - JOUR
TI  - Brève : La FDA autorise un test BioMérieux coronavirus sur échantillons groupés.
AU  - Manus JM
PY  - 2021
JO  - Revue francophone des laboratoires : RFL
DO  - 10.1016/s1773-035x(21)00045-9
UR  - https://doi.org/10.1016/s1773-035x(21)00045-9
ER  -

APA

JM, M. (2021). Brève : La FDA autorise un test BioMérieux coronavirus sur échantillons groupés.. Revue francophone des laboratoires : RFL. https://doi.org/10.1016/s1773-035x(21)00045-9

Source records

pubmed · retrieved 2026-09-26T16:01:10.175Z